HomeBTAI • NASDAQ
add
BioXcel Therapeutics Inc
Previous close
$1.34
Day range
$1.21 - $1.42
Year range
$1.15 - $8.08
Market cap
33.55M USD
Avg Volume
2.27M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 256.00K | -30.05% |
Operating expense | 10.51M | 5.11% |
Net income | -12.54M | -15.53% |
Net profit margin | -4.90K | -65.17% |
Earnings per share | — | — |
EBITDA | -10.21M | 1.69% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 28.42M | -4.82% |
Total assets | 44.92M | 17.16% |
Total liabilities | 140.38M | 6.80% |
Total equity | -95.46M | — |
Shares outstanding | 27.07M | — |
Price to book | -0.31 | — |
Return on assets | -57.31% | — |
Return on capital | -148.74% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -12.54M | -15.53% |
Cash from operations | -14.21M | 4.04% |
Cash from investing | — | — |
Cash from financing | 5.65M | 32.06% |
Net change in cash | -8.56M | 18.70% |
Free cash flow | -8.11M | 32.66% |
About
Founded
2017
Headquarters
Website
Employees
29
